Shayne Heffernan

Thoughts

Five streams. What I think about artificial intelligence, what I think about thinking, what I think about markets, what the longevity evidence actually supports, and the parts of life that have nothing to do with either. All of it published at Live Trading News.

AI

The build-out, the quantum timeline, and what any of it is actually for.

154 recent

Thinking

Judgement, independence, and staying non-fungible in an AI world.

24 recent

Markets

Stocks, macro, ramblings and the KXCO build.

162 recent across four streams

Longevity

Healthspan science, and separating the evidence from the sales pitch.

28 recent

Life

Food, travel, sport, and the unoptimised parts that refill the well.

12 recent

Latest

18 November 2026

Industrialising Intelligence: Demand, Scarcity and the Boundary of Sovereignty

AI agents generate 80% of OpenRouter's tokens, about seven times human use, and Google's monthly tokens rose about 330 times in two years to over 3.2 quadrillion. In my view the limit on AI demand has moved from people to power: the International Energy Agency expects data-centre electricity to reach around 945 terawatt-hours by 2030. Execution is becoming a utility. Selection is not. KXCO builds the boundary that keeps the decision with a named person and lets another party check the record.

18 November 2026

Thoughts on Thinking: Brain Essentials

Your brain runs on about 20 watts. The fastest supercomputer outruns it, but at the central published estimate the brain is about 680 times as efficient per watt as the best machine on the November 2026 Green500. It runs on four inputs most people overlook. Creatine buffers its energy, DHA builds its membranes, exercise raises its growth factors and, in older adults, enlarges the hippocampus, and low vitamin D goes with slower processing and more dementia.

17 November 2026

KXCO's FDA Ontology Is Two for Two on FDA Decisions

The FDA has decided two filings on KXCO's FDA board since the board began ranking them, and on my scorecard the board got both right. It ranked Inovio's INO-3107 first and the FDA approved it on 30 October; Inovio moved +149.1% net of the sector. It gave Summit's ivonescimab no call, and Summit announced the FDA's refusal on 15 November; Summit fell 16.5%. KXCO's record held the FDA's survival warning before the refusal was announced.

16 November 2026

Quantum Computing in November 2026: The Cost of Breaking Your Keys Keeps Falling

No quantum computer can break today's public keys yet, but three new estimates and a peer-reviewed Google paper put a break at between 19,397 and 500,000 physical qubits. Quantinuum's Helios has 98 qubits and IBM's Nighthawk r2 has 120. NIST will deprecate RSA and elliptic-curve cryptography after 2030, and only about 15% of the origin servers behind Cloudflare use post-quantum key exchange. KXCO's core library, kxco-post-quantum, scores 9.8 on the OpenSSF Scorecard.

16 November 2026

The Week Ahead on Wall Street, 16 November 2026: Look for the Bounce

NVIDIA reports on Tuesday 17 November 2026, its first results since Jensen Huang resigned, and I expect the stock and the AI market to bounce. NVIDIA closed at $162.85 on 13 November 2026, 31.93% below its record, while the semiconductor index rose 8.05% on the week. The calendar leans to currencies, with the yen near 160 after briefly crossing it, and the US publishes retail sales, housing starts, jobless claims and the Fed's minutes. Follow them on the Live Trading News trading page.

15 November 2026

KXCO's FDA Ontology Ranked INO-3107 First. Its Two Published Books Beat XBI.

KXCO's FDA ontology ranked INO-3107 first before the FDA approved it on 30 October 2026; Inovio (INO) then hit $2.71 after hours from a $0.60 close. KXCO's two published research books on the ontology stood at 109.31 and 110.28 at the close of 13 November, from 100 at the close of 14 October, against 102.58 for XBI. Nine more decisions on the board fall due before 31 December, starting with molgramostim (SVRA) and deramiocel (CAPR) on 22 November.

15 November 2026

AI Is Still a Buy: The Noise Will Not Stop the Build-Out

In my view AI is still a buy. NVIDIA announced on 12 November 2026 that Jensen Huang had resigned as chief executive, and the push against data centres widened, yet four of the largest cloud sellers carry about $2.48 trillion of signed backlog and the build kept moving. NVIDIA closed at $162.85 on 13 November 2026 with an average analyst target 71.71% above the price. KXCO's AI ontology shows the same US companies have announced capacity in the UAE, Saudi Arabia, Japan, Malaysia and India.

13 November 2026

Jensen Huang, Nvidia and the Morality Game America Plays With Itself

Jensen Huang resigned as Nvidia's chief executive on 12 November 2026 after reports of three relationships. Whether a foreign service reached him, and whether ties to staff broke Nvidia's own conflict rules, are questions for investigators and the board. His marriage is not. A third of Americans say they have cheated on a partner or spouse, and US fans spent an estimated $4.9 billion on OnlyFans in a year. The outrage is selective, and it is never aimed at the audience.

The full archive on Live Trading News